AMGN
Amgen Inc. · Healthcare · Drug Manufacturers - General
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 171 | -1 | 369.42M | $133.70B | +5 | −5 |
| Q1 2026 | 174 | -2 | 366.40M | $128.82B | +4 | −7 |
| Q4 2025 | 175 | 0 | 394.29M | $128.98B | +2 | −1 |
| Q3 2025 | 26 | 0 | 206.42M | $58.23B | — | −1 |
| Q2 2025 | 24 | +1 | 183.25M | $51.15B | +2 | −1 |
| Q1 2025 | 20 | -2 | 81.79M | $25.47B | — | −2 |
| Q4 2024 | 22 | +2 | 74.78M | $19.48B | +2 | — |
| Q3 2024 | 19 | -1 | 39.65M | $12.76B | +1 | −2 |
| Q2 2024 | 20 | — | 39.58M | $12.36B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 14.45M | — | $4.51B | 3.3% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 12.02M | — | $3.75B | 0.3% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 12.02M | — | $3.75B | 0.3% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (passive) | 5.81M | — | $1.81B | 0.3% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 4.52M | — | $1.41B | 0.2% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 4.52M | — | $1.41B | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Marshall Wace ✦ | 656.50K | — | $205.12M | 0.3% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 656.50K | — | $205.12M | 0.3% | n/c | 1 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 578.30K | — | $180.69M | 0.3% | n/c | 1 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 542.15K | — | $169.39M | 0.4% | n/c | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 306.68K | — | $95.82M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 306.68K | — | $95.82M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 234.41K | — | $73.24M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 234.41K | — | $73.24M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Wellington Management ✦ | 234.41K | — | $73.24M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 234.41K | — | $73.24M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 234.41K | — | $73.24M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 234.41K | — | $73.24M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 234.41K | — | $73.24M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 234.41K | — | $73.24M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 84.38K | — | $26.36M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | ARK Investment Management ✦ | 74.82K | — | $23.38M | 0.2% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 73.12K | — | $22.85M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 73.12K | — | $22.85M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 73.12K | — | $22.85M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Millennium Management ✦ | 67.21K | — | $21.00M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Renaissance Technologies ✦ | 52.24K | — | $16.32M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Arrowstreet Capital ✦ | 37.27K | — | $11.65M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 22.81K | — | $7.13M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Gotham Asset Management ✦ | 22.14K | — | $6.92M | 0.1% | n/c | 1 | SEC ↗ |
| 31 | Dodge & Cox ✦ | 14.38K | — | $4.49M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Bridgewater Associates ✦ | 8.73K | — | $2.73M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | GAMCO Investors ✦ | 5.59K | — | $1.75M | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 60.20K shares, $21,181 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.25K sh · $521,365
Officer · 2.00K sh · $825,134
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology